•
Dec 31, 2017

Corcept Therapeutics Q4 2017 Earnings Report

Total Revenue
$53.3M
Previous year: $23.8M
+123.9%
EPS
$0.19
Previous year: $0.04
+375.0%
Gross Profit
$52.1M
Previous year: $23.3M
+124.2%
Cash and Equivalents
$31.1M
Previous year: $51.5M
-39.7%
Free Cash Flow
$24.9M
Previous year: $18.3M
+35.7%
Total Assets
$221M
Previous year: $68.8M
+220.8%

Corcept Therapeutics

Corcept Therapeutics